Haemonetics Corporation

S&P 500

HAE/Healthcare · Medical Devices/NYSE

Stock Price

$77.62

Stock Price$77.62P/E35.7MCap3.3BLast update: Jun 26, 2026 at 06:56

Dividend Safety Rating

N/A/ 100

Dividend Safety Rating

HAE does not currently pay a dividend. The Dividend Safety Rating is not applicable for non-dividend stocks.

About Haemonetics Corporation

Haemonetics Corporation is a global healthcare company dedicated to providing innovative blood management solutions for organizations around the world. The company plays a crucial role in the healthcare industry by offering devices and services that aim to improve the quality, efficiency, and safety of blood supply. Haemonetics is known for its comprehensive portfolio, which includes blood collection and processing systems, plasma collection devices, and software solutions for blood centers and hospitals. The core focus of Haemonetics' offerings lies in enhancing blood donor and patient care, optimizing blood banks' operations, and ensuring the safety and availability of blood and blood components. It serves a wide array of sectors, including hospitals, blood centers, and plasma collection centers, facilitating the global demand for transfusion medicine. With its headquarters in Boston, Massachusetts, Haemonetics continues to influence the landscape of healthcare through its commitment to innovation and its significant contributions to enhancing blood management practices. By catering to a vital segment of the healthcare system, Haemonetics Corporation supports the delivery of essential medical treatments and therapies worldwide.

Dividend Overview

Dividend Yield

0.00%

Annual Dividend

$0.00

Frequency

N/A

Payout Ratio

0.00%

FCF Payout Ratio

0.00%

52-Week Range

$47.32 - $87.32

Earnings & Profitability

HAE earnings per share and net profit margin

Key Dates

Next Ex-Dividend Date

—

Next Payment Date

—

Dividend Growth

3-Year Dividend CAGR

N/A

5-Year Dividend CAGR

N/A

10-Year Dividend CAGR

N/A

3-Year Total Growth

N/A

5-Year Total Growth

N/A

10-Year Total Growth

N/A

Income Calculator

HAE Dividend Calculator

Number of Shares

Total Investment

$7,762.00

Annual Income

$0.00

Quarterly Income

$0.00

Monthly Income

$0.00

Frequently Asked Questions

What is HAE's current dividend yield?

Haemonetics Corporation (HAE) currently has a dividend yield of 0.00%, based on a stock price of $77.62 and an annual dividend of $0.00.

When is HAE's next dividend payment date?

HAE's next ex-dividend date is — and the next payment date is —. You must own the stock before the ex-dividend date to receive the upcoming payment.

How much does HAE pay in dividends per year?

Haemonetics Corporation pays dividends unknown. Annual dividend data is not yet available.

Has HAE been increasing its dividend?

Haemonetics Corporation has grown its dividend at a 5-year CAGR of —.

Is HAE's dividend safe?

Haemonetics Corporation has a payout ratio of 0.00%. Its free cash flow payout ratio is 0.00%. A payout ratio below 60% is generally considered sustainable.

How is HAE's Dividend Safety Rating calculated?

The Dividend Safety Rating evaluates Haemonetics Corporation's dividend sustainability across four categories: Payout & Coverage (30%), Balance Sheet (20%), Profitability (20%), and Dividend Track Record (30%). Each metric is rated from "Very Safe" to "Danger" based on industry-standard thresholds, with sector-specific adjustments for healthcare companies. The overall score ranges from 0 to 100.

Want to understand how we rate dividend safety? Read our full methodology

Track HAE Dividends with OnlyDividends

What will HAE actually pay you after taxes? Track every payout, get notified on payment dates, and stop guessing.

This page is not investment advice. The content is for informational purposes only and should not be construed as a recommendation to buy, sell, or hold any security. Always do your own research and consult a qualified financial advisor before making investment decisions.

Financial data, including dividend history, earnings, balance sheet metrics, and the Dividend Safety Rating, is provided for informational purposes only. Data may be delayed or differ from official filings. Past performance does not guarantee future results. Always verify with official sources before making investment decisions.

Market data provided by Twelve Data.